Dasen


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 13.3%
Influenza 12.4%
Drug Eruption 9.6%
Nasopharyngitis 9.2%
Otitis Media Acute 8.0%
Pharyngitis 7.2%
Hypertension 6.8%
Acute Sinusitis 4.4%
Prophylaxis Against Gastrointestinal Ulcer 3.6%
Pain 3.2%
Tonsillitis 3.2%
Bronchitis 2.4%
Cough 2.4%
Hepatitis C 2.4%
Hyperlipidaemia 2.4%
Upper Respiratory Tract Inflammation 2.4%
Insomnia 2.0%
Analgesic Therapy 1.6%
Depression 1.6%
Labyrinthitis 1.6%
Stevens-johnson Syndrome 14.6%
Urticaria 7.3%
Anaphylactic Shock 4.9%
Cardiac Failure Acute 4.9%
Drug Eruption 4.9%
Erythema Multiforme 4.9%
Hepatic Function Abnormal 4.9%
Mucous Membrane Disorder 4.9%
Myoclonus 4.9%
Pelvic Venous Thrombosis 4.9%
Restlessness 4.9%
Tongue Disorder 4.9%
Transfusion-related Acute Lung Injury 4.9%
Urinary Incontinence 4.9%
Vomiting 4.9%
White Blood Cell Count Decreased 4.9%
Abnormal Behaviour 2.4%
Body Temperature Decreased 2.4%
Chills 2.4%
Diarrhoea Haemorrhagic 2.4%
Concomitant
Drug Use For Unknown Indication 11.8%
Bronchitis 10.2%
Hypertension 9.0%
Product Used For Unknown Indication 7.2%
Prophylaxis 6.6%
Nasopharyngitis 6.3%
Influenza 5.6%
Pneumonia 5.4%
Behcet's Syndrome 4.9%
Upper Respiratory Tract Inflammation 4.7%
Gastritis 3.5%
Asthma 3.4%
Pharyngitis 3.3%
Insomnia 3.1%
Constipation 3.0%
Infection Prophylaxis 2.6%
Cough 2.5%
Rheumatoid Arthritis 2.4%
Diabetes Mellitus 2.2%
Respiratory Tract Infection 2.2%
Interstitial Lung Disease 13.0%
Vomiting 11.2%
Drug Exposure During Pregnancy 9.8%
Rhabdomyolysis 8.8%
Pneumonia 5.6%
Urticaria 4.7%
Loss Of Consciousness 4.2%
Tremor 4.2%
Abnormal Behaviour 3.7%
Death 3.7%
Drug Eruption 3.7%
Nausea 3.7%
White Blood Cell Count Increased 3.7%
Weight Decreased 3.3%
Aspiration 2.8%
Enterocolitis Haemorrhagic 2.8%
Haemoptysis 2.8%
Pyrexia 2.8%
Restlessness 2.8%
Staphylococcal Infection 2.8%

Drug Data